Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-098044
Filing Date
2025-07-23
Accepted
2025-07-23 19:40:12
Documents
1
Period of Report
2025-07-23

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3879
  Complete submission text file 0000950170-25-098044.txt   5498
Mailing Address C/O PAREXEL INTERNATIONAL CORPORATION WALTHAM MA 02451-1163
Business Address
VON RICKENBACH JOSEF H (Reporting) CIK: 0001007706 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38130 | Film No.: 251144200

Mailing Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758
Business Address 12407 N. MOPAC EXPY. SUITE 250 #390 AUSTIN TX 78758 7378021989
Rein Therapeutics, Inc. (Issuer) CIK: 0001420565 (see all company filings)

EIN.: 134196017 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)